Biopharma

CaroGen Partners with BioCentriq™ for Clinical Production of its Novel Immunotherapy CARG-201

Amy Lamperti | New Jersey Innovation Institute

CaroGen has selected BioCentriq as their manufacturing partner for CARG-201, a potential functional cure for patients chronically infected with hepatitis B virus (HBV). CaroGen Corporation has selected BioCentriq™ as their partner for clinical manufacturing to support Phase 1 clinical trials of its lead immunotherapy candidate, CARG-201 which has been designed to generate multiple hepatitis B virus (HBV) antigens and to …

Argent Ventures And H&R REIT Launch The Cove JC, A Super-Connected Innovation Community For The 21st Century In Jersey City Just Minutes From Manhattan

Heather Scott | PR Newswire

A joint venture between Argent Ventures and H&R REIT announced today the launch of The Cove JC, a global hub for life science, tech and medicine offering an unrivalled ecosystem for discovery that will become the premier flagship destination for academic and commercial life science, tech and medical entities in New Jersey and the Greater New York Metropolitan Area. Connected to NYC and New Jersey and served …

Passage Bio Announces Gene Therapy Manufacturing Research and Development Site

Passage Bio | GlobeNewswire

PHILADELPHIA, Dec. 16, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced that it has entered into a long-term lease to support Chemistry, Manufacturing and Controls (CMC) laboratory operations for the company’s gene therapy programs. The new laboratory, slated to open …

Evergreen Theragnostics Breaks Ground on Radiopharmaceutical Factory

Mark Terry | BioSpace

Evergreen Theragnostics, located in Jersey City, New Jersey, broke ground for its new manufacturing plant in Springfield, New Jersey. Evergreen is a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). The new facility will be 14,000 square feet and is designed from start to finish to meet global current Good Manufacturing Practice (cGMP) standards for radiopharmaceutical manufacturing. This includes both therapeutic …

Somerset-Based Whizai Gets $4 Million to Make Business Intelligence Easy for Pharma and Life Sciences

Esther Surden | NJ Tech Weekly

WhizAI (Somerset) has an artificial intelligence (AI) technology for the business end of the pharmaceutical and life-science industries that some observers have described as “magical.” The company recently secured an additional $4 million in funding to further scale its software offering. According to WhizAI cofounder and CEO Rohit Vashisht, he and cofounder Amitabh Patil started the company in 2017 with the …

EY names Entrepreneur of the Year New Jersey Award finalists

Eric Strauss | ROI-NJ

Ernst & Young LLP has announced the 30 finalists for its Entrepreneur of the Year 2020 New Jersey Award, with honorees from sectors ranging from food to pharma and finance. The Entrepreneur of the Year program honors business leaders who are building and sustaining groundbreaking companies that transform the world, the professional services firm — which has a major presence …

Innovating During COVID-19: New Jersey’s Next Era in Life Sciences

Choose New Jersey | Area Development

Following 150 years of global leadership in life sciences, cell and gene therapy (CGT) is rapidly accelerating within the New Jersey ecosystem. As winter began to wane this year, the world was upended by the COVID-19 pandemic. Unprecedented levels of interest in cell and gene therapies have followed, with research and development (R&D) facilities testing different potential solutions, such as …

RUCDR Infinite Biologics to Provide 30,000 Rapid Response COVID-19 Tests Per Day

Jim Pytell | New Jersey Business Magazine

At what was his 100th COVID-19 press briefing, Gov. Phil Murphy today announced that RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey, will provide 30,000 rapid-response saliva-based coronavirus tests per day. “Having these tests means we now have 30,000 tests a day that come with a 48-hour turnaround. As test turnaround has lagged nationally given …

BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment

NEW JERSEY BUSINESS MAGAZINE

North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia. BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Director of Creative & Digital Marketing
Tiffany Hess-Bennette
Editorial Content Manager